Search alternatives:
significant attention » significant potential (Expand Search), significant reduction (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant attention » significant potential (Expand Search), significant reduction (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
1
-
2
-
3
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”
-
4
-
5
-
6
ECoG timescales decrease during spatial attention.
Published 2025“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
-
7
-
8
-
9
-
10
Signal strength of reports of finasteride administration in female at the PT level.
Published 2025Subjects: -
11
Signal strength of reports of finasteride administration in male at the PT level.
Published 2025Subjects: -
12
-
13
Signal strength of reports of finasteride administration at the PT level (age < 18).
Published 2025Subjects: -
14
Signal strength of reports of finasteride administration at the PT level (age>=65).
Published 2025Subjects: -
15
Number of adverse reaction case reports of finasteride administration at the PT level.
Published 2025Subjects: -
16
-
17
-
18
Signal strength of reports of finasteride administration at the PT level (age = 18-65).
Published 2025Subjects: -
19
-
20
Metabolites with decreasing levels during the development.
Published 2025“…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly decreasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”